StockNews.com started coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research note released on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock.
Organovo Price Performance
Shares of ONVO opened at $0.57 on Thursday. The company’s fifty day moving average price is $0.69 and its 200-day moving average price is $0.90. Organovo has a 1-year low of $0.50 and a 1-year high of $2.05.
Organovo (NASDAQ:ONVO – Get Free Report) last issued its quarterly earnings results on Friday, May 31st. The medical research company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.13. The firm had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.08 million. As a group, equities research analysts predict that Organovo will post -0.96 EPS for the current fiscal year.
Institutional Trading of Organovo
About Organovo
Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
See Also
- Five stocks we like better than Organovo
- What is the Shanghai Stock Exchange Composite Index?
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Find and Profitably Trade Stocks at 52-Week Lows
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.